Your browser doesn't support javascript.
[The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19].
Ma, Wan-Xia; Ran, Xing-Wu.
  • Ma WX; Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Ran XW; Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 51(2): 146-150, 2020 Mar.
Artigo em Chinês | MEDLINE | ID: covidwho-18395
ABSTRACT
Based on the higher mortality and the higher proportion of critically ill adults in coronavirus disease 2019 (COVID-19) patients with diabetes, good inpatient glycemic control is particularly important in the comprehensive treatment of COVID-19. Individualized blood glucose target goals and treatment strategies should be made according to specific circumstances of COVID-19 inpatients with diabetes. For mild patients, a strict glycemic control target (fasting plasma glucose (FPG) 4.4-6.1 mmol/L, 2-hour postprandial plasma glucose (2 h PG) 6.1-7.8 mmol/L) are recommended; a target for the glycemic control of common type patients (FPG 6.1-7.8 mmol/L, 2 h PG 7.8-10.0 mmol/L) and subcutaneous insulin deliver therapy are recommended; a target nonfasting blood glucose range of 10.0 mmol or less per liter for severe-type COVID-19 patients, a relatively Less stringent blood glucose control target (FPG 7.8-10.0 mmol/L, 2 h PG 7.8-13.9 mmol/L) for critically ill patients and intravenous insulin infusion therapy are recommended. Due to the rapid changes in the condition of some patients, the risk of diabetic ketoacidosis (DKA) or hyperglycemic hyperosmolar status (HHS) maybe occur during the treatment. Blood glucose monitoring, dynamic evaluation and timely adjustment of strategies should be strengthened to ensure patient safety and promote early recovery of patients.
Assuntos
Palavras-chave

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Glicemia / Infecções por Coronavirus / Diabetes Mellitus Tipo 2 / Betacoronavirus / Hipoglicemiantes / Insulina Tipo de estudo: Estudo experimental / Estudo prognóstico Tópicos: Covid persistente Limite: Adulto / Humanos Idioma: Chinês Revista: Sichuan Da Xue Xue Bao Yi Xue Ban Ano de publicação: 2020 Tipo de documento: Artigo País de afiliação: 20200360606

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Glicemia / Infecções por Coronavirus / Diabetes Mellitus Tipo 2 / Betacoronavirus / Hipoglicemiantes / Insulina Tipo de estudo: Estudo experimental / Estudo prognóstico Tópicos: Covid persistente Limite: Adulto / Humanos Idioma: Chinês Revista: Sichuan Da Xue Xue Bao Yi Xue Ban Ano de publicação: 2020 Tipo de documento: Artigo País de afiliação: 20200360606